Eurofins Scient
Eurofins Scient
2,39 %
386,00 EUR
9,00
Kurs
386,00
Hög
390,00
Förändring
2,39 %
Låg
379,60
Uppdaterad
2019-07-19
Öppen
380,00
Factsheet for Eurofins Scient
Company Profile
Description
Eurofins Scientific SE is a Belgian life sciences company that provides bioanalytical testing services for food, environment, and pharmaceutical products to clients in a variety of industries, including agricultural science and pharmaceutical firms. Eurofins' testing services evaluate the safety, composition, and purity of biological substances. The food and feed segment performs tests to help develop, produce, and distribute food products. Eurofins' environmental segment tests water, air, and soil for contaminants and pollutants. The pharmaceutical segment helps clients conduct clinical trials for drugs in development. The majority of the firm's revenue is generated in North America and Europe, with sales in France making up the largest percentage of European revenue.
Key Stats
Website: http://www.eurofins.com
Headquarter country: Luxembourg
Employees: 17 144
Market Cap (at close 19-07-2019): EUR 7B
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 30,50 47,00 56,20 60,40 64,00
Forward Price/Earnings 15,80 28,40 31,30 27,20 29,90
Price/Free Cash Flow 33,60 59,20 44,90 47,50 70,40
Return on Assets 3,40 4,40 4,40 3,10 4,70
Return on Equity 8,80 10,70 13,50 10,80 15,20
Return on Invested Capital 5,10 6,70 7,60 5,90 8,40
Dividend


Dividend/Share:2,40
Ex. Dividend Date:2018-12-31
Trailing Dividend Yield:0,75
Payout Ratio:25,05
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 3 781,15 2 971,42 2 536,61 1 950,07 1 410,23
Gross Profit 2,43 1,91 1,64 1,26 0,92
Gross Margin % 64,33% 64,18% 64,62% 64,87% 65,01%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 653,00 517,00 477,00 318,00 225,00
Net income 224,00 217,00 174,00 87,00 79,00
Basic Earnings Per Share 9,91 10,49 10,88 5,71 5,15
Operating Income 0,34 0,29 0,28 0,21 0,13
Operating Margin % 8,93% 9,67% 11,03% 10,51% 9,45%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 544,00 405,00 372,00 291,00 212,00
Capital Expenditures -364,00 -246,00 -200,00 -169,00 -135,00
Free Cash Flow 179,00 159,00 172,00 122,00 78,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 1 705,40 1 826,58 1 579,41 1 424,31 621,07 644,54
Long Term Assets 5 500,04 4 005,73 2 550,00 2 275,53 1 252,12 852,47
Total Assets 7 205,45 5 832,31 4 129,42 3 699,83 1 873,19 1 497,02
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 1 450,66 1 451,89 710,01 774,97 451,51 338,71
Long Term Liabilities 1 937,24 1 791,93 1 967,52
Total Liabilities 3 389,14 2 501,94 2 742,49
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings 659,24 522,88 287,28 158,79 220,99 154,24
Treasury Stock 0,18
Total Stockholder Equity 2 669,19 2 443,17 1 627,48 957,34 656,48 387,69
Net Tangible Assets -1 696,05 -797,29 -340,38 -806,03 -216,08 -155,08